Gambaryan, Stepan; Friebe, Andreas; Walter, Ulrich
Does the NO/sGC/cGMP/PKG pathway play a stimulatory role in platelets?BLOOD. Bd. 119. H. 22. 2012 S. 5335-5336
Schwentner, L.; Van Ewijk, R.; Kurzeder, C. et al.
Does the Participation in adjuvant Studies improve the Survival Chances in Comparison to Treatment for Breast Cancer according to guide-linesGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 72. H. 7. 2012 S. P69-P69
Keilmann, A; Moein, G; Scholer, H
Does the SETK 3-5 detect clinically diagnosed language impairment?HNO. Bd. 60. H. 1. 2012 S. 63-70
Sharopov, S; Moser, J; Chen, RQ et al.
Dopaminergic modulation of low-Mg2+-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitroJOURNAL OF NEUROSCIENCE RESEARCH. Bd. 90. H. 10. 2012 S. 2020-2033
Steubl, D; Papachristou, E; Wolf, P et al.
Doppler-Ultrasound measurements in renal allografts depend on the patient's body positionVASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. Bd. 41. H. 2. 2012 S. 114-119
Ganten, T; Worns, MA; Siveke, J et al.
DOSE ESCALATION OF THE HDAC INHIBITOR RESMINOSTAT IN COMBINATION TREATMENT WITH SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMAANNALS OF ONCOLOGY. Bd. 23. 2012 S. 55-55
Blaickner, M; Kratz, JV; Minouchehr, S et al.
Dosimetric feasibility study for an extracorporeal BNCT application on liver metastases at the TRIGA MainzAPPLIED RADIATION AND ISOTOPES. Bd. 70. H. 1. 2012 S. 139-143
Knapstein, J.; Heise, M.; Lautem, A. et al.
DOWNREGULATION OF ORGANIC CATION TRANSPORTERS OCT1 (SLC22A1) AND OCT3 (SLC22A3) IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR PROGNOSTIC SIGNIFICANCEJOURNAL OF HEPATOLOGY. Bd. 56. 2012 S. S118-S118
Heise, M; Lautem, A; Knapstein, J et al.
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceBMC CANCER. Bd. 12. 2012 S. -
Wesarg, S.; Kirschner, M.; Becker, M. et al.
Dual-energy CT-based Assessment of the Trabecular Bone in VertebraeMETHODS OF INFORMATION IN MEDICINE. Bd. 51. H. 5. 2012 S. 398-405